Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

66.27 

0.65 1.0%

as of Dec 13 '19

52 Week Range:

46.20 69.24


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services. The company's Retail/LTC segment sells prescription drugs and general merchandise, such as over-the-counter drugs, beauty products, cosmetics, and personal care products, as well as provides health care services through its MinuteClinic walk-in medical clinics. Its Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management, Medicare plans, PDPs, Medicaid health care management services, workers' compensation administrative services, and health information technology products and services. The company's customers include employers, insurance companies, unions, government employee groups, health plans, Medicare Part D prescription drug plans, Medicaid managed care plans, plans offered on public health insurance exchanges and private health insurance exchanges, other sponsors of health benefit plans, individuals, college students, workers, labor groups, and expatriates. As of December 31, 2018, it had approximately 40 leased on-site pharmacies, 25 leased retail specialty pharmacy stores, 20 specialty mail order pharmacies, and 90 branches for infusion and enteral services; and 9,900 retail locations and 1,100 MinuteClinic locations, as well as operated an online retail pharmacy Websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 16.54
17.88
20.32
22.30
22.64
23.75
27.50
30.91
32.05
28.80
24.74
growth rate 8.1% 13.7% 9.7% 1.5% 4.9% 15.8% 12.4% 3.7% -10.1% -14.1%
Earnings BIT 8,824.00
9,695.00
10,576.00
9,828.00
9,713.00
growth rate 9.9% 9.1% -7.1% -1.2%
Avg.PE 15.37
12.70
17.76
growth rate -17.4% 39.8%
ROA 5.53
6.03
5.54
5.46
5.94
6.68
6.37
6.24
5.65
6.99
-0.41
growth rate 9.0% -8.1% -1.4% 8.8% 12.5% -4.6% -2.0% -9.5% 23.7% -100.0%
ROE 9.76
10.54
9.33
9.14
10.24
12.14
12.24
13.94
14.37
17.77
-1.24
growth rate 8.0% -11.5% -2.0% 12.0% 18.6% 0.8% 13.9% 3.1% 23.7% -100.0%
ROIC 7.29
8.67
7.97
8.02
8.87
9.96
9.85
9.93
9.23
11.23
1.34
growth rate 18.9% -8.1% 0.6% 10.6% 12.3% -1.1% 0.8% -7.1% 21.7% -88.1%
Cur. Ratio 1.23
1.43
1.60
1.56
1.44
1.64
1.37
1.31
1.18
1.01
1.03
growth rate 16.3% 11.9% -2.5% -7.7% 13.9% -16.5% -4.4% -9.9% -14.4% 2.0%
Quick Ratio 0.50
0.53
0.57
0.62
0.57
0.84
0.64
0.62
0.60
0.48
0.55
growth rate 6.0% 7.6% 8.8% -8.1% 47.4% -23.8% -3.1% -3.2% -20.0% 14.6%
Leverage 1.77
1.72
1.65
1.70
1.75
1.89
1.96
2.52
2.56
2.52
3.37
growth rate -2.8% -4.1% 3.0% 2.9% 8.0% 3.7% 28.6% 1.6% -1.6% 33.7%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 9,687.00
11,888.00
12,164.00
13,181.00
17,631.00
growth rate 22.7% 2.3% 8.4% 33.8%
Acct.Payable 6,547.00
7,490.00
7,946.00
8,863.00
8,925.00
growth rate 14.4% 6.1% 11.5% 0.7%
Cur.Assets 25,983.00
29,158.00
31,042.00
31,229.00
45,243.00
growth rate 12.2% 6.5% 0.6% 44.9%
Total Assets 74,187.00
92,437.00
94,462.00
95,131.00
196,456.00
growth rate 24.6% 2.2% 0.7% 106.5%
Cash 2,481.00
2,459.00
3,371.00
1,696.00
4,059.00
growth rate -0.9% 37.1% -49.7% 139.3%
Inventory 11,930.00
14,001.00
14,760.00
15,296.00
16,450.00
growth rate 17.4% 5.4% 3.6% 7.5%
Cur.Liabilities 19,027.00
23,169.00
26,250.00
30,648.00
44,009.00
growth rate 21.8% 13.3% 16.8% 43.6%
Liabilities 36,224.00
55,195.00
57,628.00
57,436.00
137,913.00
growth rate 52.4% 4.4% -0.3% 140.1%
LT Debt 11,630.00
26,267.00
25,615.00
22,181.00
71,444.00
growth rate 125.9% -2.5% -13.4% 222.1%
Equity 37,958.00
37,196.00
36,830.00
37,691.00
58,225.00
growth rate -2.0% -1.0% 2.3% 54.5%
Common Shares 1,469.00
1,450.00
1,377.00
1,347.00
1,280.00
1,226.00
1,169.00
1,126.00
1,079.00
1,024.00
1,044.00
growth rate -1.3% -5.0% -2.2% -5.0% -4.2% -4.7% -3.7% -4.2% -5.1% 2.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 2,136.00
2,367.00
2,224.00
1,918.00
2,037.00
growth rate 10.8% -6.0% -13.8% 6.2%
Cash Dividends 1,288.00
1,576.00
1,840.00
2,049.00
2,038.00
growth rate 22.4% 16.8% 11.4% -0.5%
Cash From OA 8,137.00
8,539.00
10,141.00
8,007.00
8,865.00
growth rate 4.9% 18.8% -21.0% 10.7%
FCF per Share 0.71
0.74
1.44
2.85
2.18
2.31
2.90
4.90
7.84
6.59
3.69
growth rate 4.2% 94.6% 97.9% -23.5% 6.0% 25.5% 69.0% 60.0% -15.9% -44.0%
Sale Purchase of Stock 421.00
362.00
296.00
329.00
growth rate -14.0% -18.2% 11.2%
FCF 1,767.00
1,487.00
2,774.00
3,984.00
4,641.00
3,799.00
6,001.00
6,045.00
7,845.00
6,089.00
6,828.00
growth rate -15.9% 86.6% 43.6% 16.5% -18.1% 58.0% 0.7% 29.8% -22.4% 12.1%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 139,367.00
153,290.00
177,526.00
184,765.00
193,919.00
growth rate 10.0% 15.8% 4.1% 5.0%
Op.Income 8,824.00
9,695.00
10,576.00
9,828.00
9,713.00
growth rate 9.9% 9.1% -7.1% -1.2%
IBT 7,678.00
8,616.00
8,637.00
8,268.00
1,406.00
growth rate 12.2% 0.2% -4.3% -83.0%
Net Income 4,644.00
5,237.00
5,317.00
6,622.00
-594.00
growth rate 12.8% 1.5% 24.5% -100.0%
EPS 2.18
2.55
2.49
2.57
3.02
3.74
3.96
4.63
4.90
6.44
-0.57
growth rate 17.0% -2.4% 3.2% 17.5% 23.8% 5.9% 16.9% 5.8% 31.4% -100.0%
Gross Profit 25,367.00
26,528.00
28,860.00
28,509.00
30,878.00
growth rate 4.6% 8.8% -1.2% 8.3%

Quarterly Statements

Item Name Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Earnings BIT 2,423.00
2,842.00
2,724.00
3,145.00
2,872.00
growth rate 17.3% -4.2% 15.5% -8.7%
Balance Sheet Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Acct.Receivable 14,837.00
17,631.00
19,509.00
18,174.00
19,789.00
growth rate 18.8% 10.7% -6.8% 8.9%
Acct.Payable 8,813.00
8,925.00
8,290.00
9,160.00
9,442.00
growth rate 1.3% -7.1% 10.5% 3.1%
Cur.Assets 71,981.00
45,243.00
47,857.00
46,901.00
48,185.00
growth rate -37.2% 5.8% -2.0% 2.7%
Total Assets 131,506.00
196,456.00
219,768.00
218,904.00
220,113.00
growth rate 49.4% 11.9% -0.4% 0.6%
Cash 41,587.00
4,059.00
5,896.00
6,063.00
5,193.00
growth rate -90.2% 45.3% 2.8% -14.4%
Inventory 14,818.00
16,450.00
15,448.00
15,511.00
16,028.00
growth rate 11.0% -6.1% 0.4% 3.3%
Cur.Liabilities 29,460.00
44,009.00
50,631.00
49,376.00
52,544.00
growth rate 49.4% 15.1% -2.5% 6.4%
Liabilities 94,884.00
137,913.00
159,762.00
157,305.00
157,180.00
growth rate 45.4% 15.8% -1.5% -0.1%
LT Debt 60,747.00
71,444.00
67,353.00
66,382.00
63,615.00
growth rate 17.6% -5.7% -1.4% -4.2%
Equity 36,618.00
58,225.00
59,686.00
61,282.00
62,614.00
growth rate 59.0% 2.5% 2.7% 2.2%
Common Shares 17.00
17.00
17.00
17.00
17.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Capital Expenditures 540.00
585.00
716.00
573.00
601.00
growth rate 8.3% 22.4% -20.0% 4.9%
Cash Dividends 510.00
510.00
649.00
657.00
646.00
growth rate 0.0% 27.3% 1.2% -1.7%
Cash From OA 1,097.00
2,479.00
1,948.00
5,338.00
2,928.00
growth rate 126.0% -21.4% 174.0% -45.2%
Sale Purchase of Stock
growth rate
FCF 557.00
1,894.00
1,232.00
4,765.00
2,327.00
growth rate 240.0% -35.0% 286.8% -51.2%
Income Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Sales 47,269.00
54,249.00
61,397.00
63,138.00
64,547.00
growth rate 14.8% 13.2% 2.8% 2.2%
Op.Income 2,423.00
2,842.00
2,724.00
3,145.00
2,872.00
growth rate 17.3% -4.2% 15.5% -8.7%
IBT 1,899.00
102.00
1,939.00
2,591.00
2,133.00
growth rate -94.6% 1,801.0% 33.6% -17.7%
Net Income 1,390.00
-419.00
1,421.00
1,936.00
1,530.00
growth rate -100.0% 100.0% 36.2% -21.0%
Gross Profit 7,328.00
9,490.00
10,691.00
11,081.00
11,260.00
growth rate 29.5% 12.7% 3.7% 1.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (33.64)

YOY Growth Grade:

D (46.10)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 18.67 18.67
EPS / Growth 3.55

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 26.9%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 26.9% 26.9% 26.9%
Future PE 0.01 12.45 24.16
Future EPS 38.45 38.45 38.45
Value Price
MOS %
0.10
-99.9%
118.31
78.5%
229.60
246.5%
MOS Price 0.05 59.16 114.80
IRT 6.70 6.70 6.70

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.